Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fatigue in chronic disease.

M G Swain1

  • 1Liver Unit, Gastroenterlogy Research Group, University of Calgary, Calgary, Alberta, Canada T2N 4N1. swain@ucalgary.ca

Clinical Science (London, England : 1979)
|July 11, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Near-Infrared Spectroscopy Reveals Brain Hypoxia and Cerebrovascular Dysregulation in Primary Biliary Cholangitis.

Hepatology (Baltimore, Md.)·2019
Same author

Letter: lipid-lowering effect of tenofovir disoproxil fumarate in chronic hepatitis B-more evidence is needed. Authors' reply.

Alimentary pharmacology & therapeutics·2017
Same author

Tenofovir disoproxil fumarate significantly decreases serum lipoprotein levels compared with entecavir nucleos(t)ide analogue therapy in chronic hepatitis B carriers.

Alimentary pharmacology & therapeutics·2017
Same author

Downregulated hypothalamic 5-HT3 receptor expression and enhanced 5-HT3 receptor antagonist-mediated improvement in fatigue-like behaviour in cholestatic rats.

Neurogastroenterology and motility·2007
Same author

Induction versus noninduction antiviral therapy for chronic hepatitis C virus in patients with congenital coagulation disorders: a Canadian multicentre trial.

Canadian journal of gastroenterology = Journal canadien de gastroenterologie·2007
Same author

Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.

Alimentary pharmacology & therapeutics·2006

Fatigue is a common but often ignored symptom in chronic disease. This review explores central fatigue mechanisms, measurement methods, and potential therapies for this distressing condition.

Area of Science:

  • Medical Research
  • Neurology
  • Quality of Life Studies

Background:

  • Fatigue is a prevalent symptom in chronic disease, frequently overlooked due to its subjective nature and lack of targeted treatments.
  • Clinicians often prioritize objective disease markers over subjective symptoms like fatigue.
  • Recent attention has focused on fatigue within health-related quality of life assessments, prompting new research avenues.

Purpose of the Study:

  • To review the mechanisms underlying central fatigue in chronic disease.
  • To discuss current methods for quantifying fatigue in clinical settings.
  • To provide an approach for managing fatigued patients with chronic conditions.

Main Methods:

  • Literature review focusing on central fatigue mechanisms in chronic disease.

Related Experiment Videos

  • Analysis of emerging methods for fatigue quantification.
  • Synthesis of clinical approaches for patient management.

    • Main Results:

    • Central fatigue in chronic disease is linked to specific brain changes.
    • New quantitative methods for fatigue assessment are increasingly used.
    • Understanding fatigue mechanisms is crucial for developing effective treatments.

    Conclusions:

    • Further research into central fatigue mechanisms is warranted.
    • Improved measurement tools can aid in clinical assessment and management.
    • Developing targeted therapies for fatigue can enhance patient quality of life.